<DOC>
	<DOCNO>NCT00477867</DOCNO>
	<brief_summary>RATIONALE : Gathering information patient ovarian cancer time may help doctor learn patient 's use medical service cost service . PURPOSE : This clinical trial collect information patient 's health use medical resource time patient stage III ovarian cancer receive paclitaxel cisplatin clinical trial GOG-172 .</brief_summary>
	<brief_title>Economic Outcomes Patients With Stage III Ovarian Cancer Receiving Paclitaxel Cisplatin Clinical Trial GOG-172</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility collect data medical resource utilization cost incur care patient stage III ovarian cancer treat intravenous ( IV ) paclitaxel cisplatin v IV paclitaxel , intraperitoneal ( IP ) paclitaxel , IP cisplatin randomize , control clinical trial . - Determine feasibility collect data resource utilization incur outside GOG institution use patient diary . - Assess work load require collect data , term mean number hour require complete medical resource utilization form . OUTLINE : Data medical resource unit consume ( include length hospital stay , length time use operating room , unit drug blood product administer , number diagnostic test receive , number physician visit need ) collect patient . Quality life assess prior randomization clinical trial GOG-172 , prior fourth course chemotherapy , sixth course chemotherapy , 3 month 6 month sixth course chemotherapy . Patients complete diary throughout treatment chemotherapy 12 month treatment . Data collect use analysis economic impact , quality life , neurotoxicity , sociologic characteristic associate treatment regimen . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 40 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage III ovarian cancer Concurrent enrollment clinical trial GOG172 require PATIENT CHARACTERISTICS : Age : Not specify Performance status : GOG 03 Life expectancy : Not specify Other : Able communicate English Spanish PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>stage III ovarian epithelial cancer</keyword>
</DOC>